ketotifen has been researched along with Staphylococcal Infections in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganir, EM | 1 |
| Capulong, MC | 1 |
| Tahara, K | 1 |
| Akasawa, A | 1 |
| Iikura, Y | 1 |
1 other study available for ketotifen and Staphylococcal Infections
| Article | Year |
|---|---|
Treatment of atopic dermatitis in children: the importance of skin care and environmental control.
Topics: Administration, Topical; Anti-Allergic Agents; Anti-Inflammatory Agents; Baths; Bedding and Linens; | 1996 |